Literature DB >> 29071478

Gene analysis of inherited antithrombin deficiency and functional analysis of abnormal antithrombin protein (N87D).

Sayaka Kamijima1, Akiko Sekiya1, Mao Takata2, Haruka Nakano1, Morika Murakami1, Tomonori Nakazato3, Hidesaku Asakura4, Eriko Morishita5,6.   

Abstract

Inherited antithrombin (AT) deficiency is one of the most clinically significant forms of congenital thrombophilia and follows an autosomal dominant mode of inheritance. We analyzed SERPINC1 in a patient who developed deep-vein thrombosis and low AT activity during pregnancy, and identified a novel missense mutation c.259A>G (p.Asn87Asp; N87D). Surprisingly, analysis of the parents' DNA showed that they did not possess this mutant, and thus, it may have been due to a de novo mutation. We also expressed this mutant AT protein in COS-1 cells and compared its intracellular localization and intracellular and extracellular antigen levels with that of wild-type AT. The expression experiment did not reveal a significant difference in the antigen levels of the mutant and wild-type AT in the cell lysate, but the mutant AT antigen level was markedly lower than that of its wild-type counterpart in the COS-1 cell supernatant. Immunofluorescence did not indicate any difference between the mutant and wild-type AT in terms of cytoplasmic localization of fluorescence signals. Our findings suggest that the patient's AT deficiency may have been caused by impaired extracellular secretion of mutant AT protein p.Asn87Asp.

Entities:  

Keywords:  Antithrombin deficiency; De novo mutation; Functional analysis; Missense mutation; Venous thrombosis

Mesh:

Substances:

Year:  2017        PMID: 29071478     DOI: 10.1007/s12185-017-2352-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.

Authors:  Rong-Fu Zhou; Qi-Hua Fu; Wen-Bin Wang; Shuang Xie; Jin Dai; Qiu-Lan Ding; Xue-Feng Wang; Hong-Li Wang; Zhen-Yi Wang
Journal:  Thromb Haemost       Date:  2005-12       Impact factor: 5.249

2.  Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.

Authors:  Keiko Maruyama; Eriko Morishita; Megumi Karato; Tadaaki Kadono; Akiko Sekiya; Yukie Goto; Tomomi Sato; Haruka Nomoto; Wataru Omi; Sachie Tsuzura; Hidenori Imai; Hidesaku Asakura; Shigeki Ohtake; Shinji Nakao
Journal:  Thromb Res       Date:  2013-06-25       Impact factor: 3.944

3.  Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.

Authors:  Akiko Sekiya; Fumina Taniguchi; Daisuke Yamaguchi; Sayaka Kamijima; Shonosuke Kaneko; Shiori Katsu; Miho Hanamura; Mao Takata; Haruka Nakano; Hidesaku Asakura; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2016-11-17       Impact factor: 2.490

4.  Molecular basis of antithrombin deficiency.

Authors:  Beate Luxembourg; Daniel Delev; Christof Geisen; Michael Spannagl; Manuela Krause; Wolfgang Miesbach; Christine Heller; Frauke Bergmann; Ursula Schmeink; Ralf Grossmann; Edelgard Lindhoff-Last; Erhard Seifried; Johannes Oldenburg; Anna Pavlova
Journal:  Thromb Haemost       Date:  2011-01-25       Impact factor: 5.249

Review 5.  Molecular genetics of human antithrombin deficiency.

Authors:  D J Perry; R W Carrell
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

Review 6.  Molecular genetics of antithrombin deficiency.

Authors:  D A Lane; G Kunz; R J Olds; S L Thein
Journal:  Blood Rev       Date:  1996-06       Impact factor: 8.250

7.  Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening.

Authors:  V Chowdhury; R J Olds; D A Lane; J Conard; I Pabinger; K Ryan; K A Bauer; M Bhavnani; U Abildgaard; G Finazzi
Journal:  Br J Haematol       Date:  1993-08       Impact factor: 6.998

8.  Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency.

Authors:  Tzu-Fei Wang; Jennifer E Dawson; Julie D Forman-Kay; Walter H A Kahr; Suzan Williams; Anthony K Chan; Riten Kumar
Journal:  Br J Haematol       Date:  2016-04-21       Impact factor: 6.998

9.  A novel and de novo spontaneous point mutation (Glu271STOP) of the antithrombin gene results in a type I deficiency and thrombophilia.

Authors:  M D Tarantino; S M Curtis; G S Johnson; J S Waye; M A Blajchman
Journal:  Am J Hematol       Date:  1999-02       Impact factor: 10.047

10.  Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.

Authors:  Steven T Olson; Richard Swanson; Elke Raub-Segall; Tina Bedsted; Morvardi Sadri; Maurice Petitou; Jean-Pascal Hérault; Jean-Marc Herbert; Ingemar Björk
Journal:  Thromb Haemost       Date:  2004-11       Impact factor: 5.249

View more
  1 in total

1.  [Phenotypic and genetic analysis of a pedigree with inherited antithrombin deficiency].

Authors:  Q Y Xu; Y H Jin; X Y Zheng; L L Yang; X L Li; H Y Zhang; M S Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.